Amgen organizacji Wskaźnik wypłaty
Jaka jest wartość Wskaźnik wypłaty organizacji Amgen?
Wartość Wskaźnik wypłaty organizacji Amgen, Inc. to -17455.17%
Jaka jest definicja Wskaźnik wypłaty?
Wskaźnik wypłat to ułamek zysków wypłaconych w formie dywidendy akcjonariuszom.
The payout ratio is calculated by dividing the dividends paid out by the net earnings for a certain period. It is usually expressed as a percentage. The part of the earnings not paid to investors is left for investment to provide for future earnings growth. Investors seeking high current income and limited capital growth prefer companies with high payout ratio. However investors seeking capital growth may prefer lower payout ratio because capital gains are taxed at a lower rate. High growth firms in early life generally have low or zero payout ratios. As they mature, they tend to return more of the earnings back to investors.
Wskaźnik wypłaty firm w Health Care sektor na XETRA w porównaniu do Amgen
Czym się zajmuję organizacja Amgen?
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Firmy z wskaźnik wypłaty podobne do Amgen
- Wartość Wskaźnik wypłaty organizacji Pental to -26648.79%
- Wartość Wskaźnik wypłaty organizacji British Land Plc to -20631.67%
- Wartość Wskaźnik wypłaty organizacji The British Land Co. Plc to -19273.26%
- Wartość Wskaźnik wypłaty organizacji Santos to -17500.00%
- Wartość Wskaźnik wypłaty organizacji Amgen to -17455.17%
- Wartość Wskaźnik wypłaty organizacji Puravankara to -14726.12%
- Wartość Wskaźnik wypłaty organizacji BASF SE to -9520.02%
- Wartość Wskaźnik wypłaty organizacji K & P International to -5537.88%
- Wartość Wskaźnik wypłaty organizacji Grainger Plc to -4734.63%
- Wartość Wskaźnik wypłaty organizacji Cuisine Solutions to -4000.00%
- Wartość Wskaźnik wypłaty organizacji SEGRO Plc to -3091.96%